Health
Vaccine news no cure for volatility, warn investors – Sydney Morning Herald
Global sharemarkets are expecting major updates on vaccine approvals in the next two months, but good news won’t counteract market volatility, investors warn.
Amid the uncertainty caused by COVID-19 shutdowns, investors have been particularly sensitive to news – positive or negative – about a potential vaccine.
At the start of July the benchmark S&P/ASX 200 rallied above the 6000 mark, gaining 1.7 per cent on a positive update from Pfizer about its project. On September 9, the local sharemarket dropped more than 2 per cent after the market digested the news that the University of Oxford and AstraZeneca had paused their phase 3 trial after an adve…
-
Noosa News15 hours agoProtest calls for shark net removal
-
General15 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News17 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
Noosa News8 hours agoYork family honours late son with tractor museum to fund cancer research